Future Products
The technological horizon of the company encompasses additional fields with enormous market potential, but will require sustained development processes. New applications will be developed in collaboration with other companies or when Fulcrum SP becomes financially independent. Mid-to-long terms applications include:
  • Stabilization of other commercial proteins and antibodies
  • Stabilization of Diagnostic Kits
  • Detection enhancing using Multiple Display capabilities
  • New generation Ultra-Filtration Membranes for Cross-flow devices with controllable pore sizes and a self-cleaning mechanism
  • Controlled Drug Delivery
    The use of SP1 for drug delivery can be applied either as part of the drug formulation or as a scaffold for protein-based drugs.
  • Ethical Drugs
    SP based drugs may enable the prevention of protein aggregation in the treatment of neuro-degenerative diseases which are associated with faulty protein aggregation.
  • Ultra-thin layers for biotech and electronic applications.